End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,980 KRW | -1.00% | +0.68% | -14.61% |
Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
Mar. 18 | JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 141
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicine
119.6
%
| 1,033,041 | 119.5 % | 1,110,007 | 119.6 % | +7.45% |
Consolidated Adjustment
-30.8
%
| -275,199 | -31.8 % | -285,690 | -30.8 % | +3.81% |
Holding Business
4.0
%
| 35,522 | 4.1 % | 36,923 | 4.0 % | +3.95% |
Medical Equipment
3.8
%
| 40,321 | 4.7 % | 35,006 | 3.8 % | -13.18% |
Others
3.4
%
| 30,851 | 3.6 % | 31,825 | 3.4 % | +3.16% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
96.7
%
| 995,821 | 87.4 % | 1,173,735 | 96.7 % | +17.87% |
Asia
2.8
%
| 32,608 | 2.9 % | 34,230 | 2.8 % | +4.97% |
Others
0.4
%
| 109,565 | 9.6 % | 5,236 | 0.4 % | -95.22% |
South America
0.0
%
| 1,741 | 0.2 % | 560 | 0.0 % | -67.83% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sung-Kweon Han
CEO | Chief Executive Officer | 66 | - |
Kyung-Ha Lee
CEO | Chief Executive Officer | 60 | - |
Ji-Woo Choi
DFI | Director of Finance/CFO | 57 | - |
Jong-Ho Lee
BRD | Director/Board Member | 91 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kyung-Ha Lee
CEO | Chief Executive Officer | 60 | - |
Jong-Ho Lee
BRD | Director/Board Member | 91 | - |
Sung-Kweon Han
CEO | Chief Executive Officer | 66 | - |
Chan-Yeop Yeom
BRD | Director/Board Member | 62 | - |
Sung-Woo Park
BRD | Director/Board Member | 60 | 18-03-21 |
Gu-Taek Oh
BRD | Director/Board Member | 59 | 17-02-15 |
Ji-Woo Choi
DFI | Director of Finance/CFO | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,924,946 | 34,003,273 ( 46.00 %) | 1,702,385 ( 2.303 %) | 46.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
JW LIFESCIENCE CORPORATION 42.98% | 6,806,168 | 42.98% | 62,841,689 $ |
1,063,535 | 99.31% | 25,753,936 $ | |
JW SHINYAK CORPORATION 30.71% | 15,615,962 | 30.71% | 23,257,165 $ |
JW HOLDINGS CORPORATION 7.48% | 5,526,062 | 7.48% | 12,827,427 $ |
DRTECH CORPORATION 4.03% | 2,973,717 | 4.03% | 7,675,877 $ |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-14.61% | 156M | |
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- A096760 Stock
- Company JW Holdings Corporation